Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ari Ristimäki

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Immunohistochemistry

Disorders

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Koski Anniina; Rajecki Maria; Guse Kilian; Kanerva Anna; Ristimäki Ari; Pesonen Sari; Escutenaire Sophie; Hemminki Akseli
Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells.
Correia Marta; Machado José Carlos; Ristimäki Ari
Basic aspects of gastric cancer.
Tuupanen Sari; Turunen Mikko; Lehtonen Rainer; Hallikas Outi; Vanharanta Sakari; Kivioja Teemu; Björklund Mikael; Wei Gonghong; Yan Jian; Niittymäki Iina; Mecklin Jukka-Pekka; Järvinen Heikki; Ristimäki Ari; Di-Bernardo Mariachiara; East Phil; Carvajal-Carmona Luis; Houlston Richard S; Tomlinson Ian; Palin Kimmo; Ukkonen Esko; Karhu Auli; Taipale Jussi; Aaltonen Lauri A
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ari Ristimäki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Koski Anniina; Rajecki Maria; Guse Kilian; Kanerva Anna; Ristimäki Ari; Pesonen Sari; Escutenaire Sophie; Hemminki Akseli
Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells.
The journal of gene medicine 2009;11(11):966-77.
2009: Correia Marta; Machado José Carlos; Ristimäki Ari
Basic aspects of gastric cancer.
Helicobacter 2009;14 Suppl 1():36-40.
2009: Tuupanen Sari; Turunen Mikko; Lehtonen Rainer; Hallikas Outi; Vanharanta Sakari; Kivioja Teemu; Björklund Mikael; Wei Gonghong; Yan Jian; Niittymäki Iina; Mecklin Jukka-Pekka; Järvinen Heikki; Ristimäki Ari; Di-Bernardo Mariachiara; East Phil; Carvajal-Carmona Luis; Houlston Richard S; Tomlinson Ian; Palin Kimmo; Ukkonen Esko; Karhu Auli; Taipale Jussi; Aaltonen Lauri A
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
Nature genetics 2009;41(8):885-90.
2009: Guse K; Diaconu I; Rajecki M; Sloniecka M; Hakkarainen T; Ristimäki A; Kanerva A; Pesonen S; Hemminki A
Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatment.
Gene therapy 2009;16(8):1009-20.
2009: Thiel Alexandra; Ganesan Aparna; Mrena Johanna; Junnila Siina; Nykänen Antti; Hemmes Annabrita; Tai Hsin-Hsiung; Monni Outi; Kokkola Arto; Haglund Caj; Petrova Tatiana V; Ristimäki Ari
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4572-80.
2009: Khanna Anchit; Böckelman Camilla; Hemmes Annabrita; Junttila Melissa R; Wiksten Jan-Patrik; Lundin Mikael; Junnila Siina; Murphy Daniel J; Evan Gerard I; Haglund Caj; Westermarck Jukka; Ristimäki Ari
MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Journal of the National Cancer Institute 2009;101(11):793-805.
2009: van Hattem W Arnout; Brosens Lodewijk A A; Marks Susan Y; Milne Anya N A; van Eeden Susanne; Iacobuzio-Donahue Christine A; Ristimäki Ari; Giardiello Francis M; Offerhaus G Johan A
Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(1):93-7.
2008: Bauerschmitz Gerd J; Ranki Tuuli; Kangasniemi Lotta; Ribacka Camilla; Eriksson Minna; Porten Marius; Herrmann Isabell; Ristimäki Ari; Virkkunen Pekka; Tarkkanen Maija; Hakkarainen Tanja; Kanerva Anna; Rein Daniel; Pesonen Sari; Hemminki Akseli
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
Cancer research 2008;68(14):5533-9.
2008: Särkioja Merja; Hakkarainen Tanja; Eriksson Minna; Ristimäki Ari; Desmond Renee A; Kanerva Anna; Hemminki Akseli
The cyclo-oxygenase 2 promoter is induced in nontarget cells following adenovirus infection, but an AU-rich 3'-untranslated region destabilization element can increase specificity.
The journal of gene medicine 2008;10(7):744-53.
2008: Alhopuro Pia; Phichith Denis; Tuupanen Sari; Sammalkorpi Heli; Nybondas Miranda; Saharinen Juha; Robinson James P; Yang Zhaohui; Chen Li-Qiong; Orntoft Torben; Mecklin Jukka-Pekka; Järvinen Heikki; Eng Charis; Moeslein Gabriela; Shibata Darryl; Houlston Richard S; Lucassen Anneke; Tomlinson Ian P M; Launonen Virpi; Ristimäki Ari; Arango Diego; Karhu Auli; Sweeney H Lee; Aaltonen Lauri A
Unregulated smooth-muscle myosin in human intestinal neoplasia.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(14):5513-8.
2008: Katajisto Pekka; Vaahtomeri Kari; Ekman Niklas; Ventelä Eeva; Ristimäki Ari; Bardeesy Nabeel; Feil Robert; DePinho Ronald A; Mäkelä Tomi P
LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis.
Nature genetics 2008;40(4):455-9.
2008: Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Oncogene 2008;27(17):2501-6.
2008: Visscher Daniel W; Pankratz V Shane; Santisteban Marta; Reynolds Carol; Ristimäki Ari; Vierkant Robert A; Lingle Wilma L; Frost Marlene H; Hartmann Lynn C
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.
Journal of the National Cancer Institute 2008;100(6):421-7.
2008: Brosens Lodewijk A A; Keller Josbert J; Pohjola Leena; Haglund Caj; Morsink Folkert H; Iacobuzio-Donahue Christine; Goggins Michael; Giardiello Francis M; Ristimäki Ari; Offerhaus G Johan A
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Cancer biology & therapy 2008;7(3):424-7.
2008: Koljonen Virve; Böhling Tom; Haglund Caj; Ristimäki Ari
Expression of HuR in Merkel cell carcinoma and in normal skin.
Journal of cutaneous pathology 2008;35(1):10-4.
2008: Alberici Paola; Gaspar Claudia; Franken Patrick; Gorski Marcin M; de Vries Ingrid; Scott Rodney J; Ristimäki Ari; Aaltonen Lauri A; Fodde Riccardo
Smad4 haploinsufficiency: a matter of dosage.
PathoGenetics 2008;1(1):2.
2008: Kanerva Anna; Lavilla-Alonso Sergio; Raki Mari; Kangasniemi Lotta; Bauerschmitz Gerd J; Takayama Koichi; Ristimäki Ari; Desmond Renee A; Hemminki Akseli
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
PloS one 2008;3(8):e2917.
2008: Eerola Hannaleena; Heinonen Mira; Heikkilä Päivi; Kilpivaara Outi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Ristimäki Ari; Nevanlinna Heli
Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2008;10(1):R17.
2007: Heinonen Mira; Fagerholm Rainer; Aaltonen Kirsimari; Kilpivaara Outi; Aittomäki Kristiina; Blomqvist Carl; Heikkilä Päivi; Haglund Caj; Nevanlinna Heli; Ristimäki Ari
Prognostic role of HuR in hereditary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6959-63.
2007: Kajanne Risto; Leppä Sirpa; Luukkainen Päivi; Ustinov Jarkko; Thiel Alexandra; Ristimäki Ari; Miettinen Päivi J
Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine.
Pediatric research 2007;62(5):570-5.
2007: Kanerva Anna; Raki Mari; Ranki Tuuli; Särkioja Merja; Koponen Jarmo; Desmond Renee A; Helin Aija; Stenman Ulf-Håkan; Isoniemi Helena; Höckerstedt Krister; Ristimäki Ari; Hemminki Akseli
Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity.
The journal of gene medicine 2007;9(1):3-9.
2007: Ranki T; Kanerva A; Ristimäki A; Hakkarainen T; Särkioja M; Kangasniemi L; Raki M; Laakkonen P; Goodison S; Hemminki A
A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
Gene therapy 2007;14(1):58-67.
2006: Mrena Johanna; Wiksten Jan-Patrik; Kokkola Arto; Nordling Stig; Haglund Caj; Ristimäki Ari
Prognostic significance of cyclin A in gastric cancer.
International journal of cancer. Journal international du cancer 2006;119(8):1897-901.
2006: Linder N; Haglund C; Lundin M; Nordling S; Ristimäki A; Kokkola A; Mrena J; Wiksten J-P; Lundin J
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.
Journal of clinical pathology 2006;59(9):965-71.
2006: Atula Timo; Hedström Johan; Ristimäki Ari; Finne Patrik; Leivo Ilmo; Markkanen-Leppänen Mari; Haglund Caj
Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.
Oncology reports 2006;16(3):485-90.
2006: Mrena J; Wiksten J-P; Nordling S; Kokkola A; Ristimäki A; Haglund C
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
Journal of clinical pathology 2006;59(6):618-23.
2006: Siironen Päivi; Ristimäki Ari; Narko Kirsi; Nordling Stig; Louhimo Johanna; Andersson Sture; Haapiainen Reijo; Haglund Caj
VEGF-C and COX-2 expression in papillary thyroid cancer.
Endocrine-related cancer 2006;13(2):465-73.
2006: Milne Anya N A; Carvalho Ralph; Morsink Folkert M; Musler Alex R; de Leng Wendy W J; Ristimäki Ari; Offerhaus G Johan A
Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(4):564-72.
2006: Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Journal of clinical pathology 2006;59(4):382-6.
2006: Thiel Alexandra; Heinonen Mira; Rintahaka Johanna; Hallikainen Tuija; Hemmes Annabrita; Dixon Dan A; Haglund Caj; Ristimäki Ari
Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.
The Journal of biological chemistry 2006;281(8):4564-9.
2005: Mrena Johanna; Wiksten Jan-Patrik; Thiel Alexandra; Kokkola Arto; Pohjola Leena; Lundin Johan; Nordling Stig; Ristimäki Ari; Haglund Caj
Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7362-8.
2005: Sudbø J; Lee J J; Lippman S M; Mork J; Sagen S; Flatner N; Ristimäki A; Sudbø A; Mao L; Zhou X; Kildal W; Evensen J F; Reith A; Dannenberg A J
Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study.
Lancet 2005;366(9494):1359-66.
2005: Erkinheimo Tiina-Liisa; Sivula Anna; Lassus Heini; Heinonen Mira; Furneaux Henry; Haglund Caj; Butzow Ralf; Ristimäki Ari
Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
Gynecologic oncology 2005;99(1):14-9.
2005: Sivula Anna; Buskens Christianne J; van Rees Bastiaan P; Haglund Caj; Offerhaus G Johan A; van Lanschot J Jan B; Ristimäki Ari
Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.
International journal of cancer. Journal international du cancer 2005;116(6):903-8.
2005: Lassus Patrik; Ristimäki Ari; Huuhtanen Riikka; Tukiainen Erkki; Asko-Seljavaara Sirpa; Andersson Leif C; Miettinen Markku; Blomqvist Carl; Haglund Caj; Böhling Tom
Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation.
Anticancer research 2005;25(4):2669-74.
2005: Tommiska Johanna; Eerola Hannaleena; Heinonen Mira; Salonen Laura; Kaare Milja; Tallila Jonna; Ristimäki Ari; von Smitten Karl; Aittomäki Kristiina; Heikkilä Päivi; Blomqvist Carl; Nevanlinna Heli
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5098-103.
2005: Narko Kirsi; Zweifel Ben; Trifan Ovidiu; Ristimäki Ari; Lane Timothy F; Hla Timothy
COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice.
Prostaglandins & other lipid mediators 2005;76(1-4):86-94.
2005: Siironen Päivi; Louhimo Johanna; Nordling Stig; Ristimäki Ari; Mäenpää Hanna; Haapiainen Reijo; Haglund Caj
Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(2):57-64.
2005: Heinonen Mira; Bono Petri; Narko Kirsi; Chang Sung-Hee; Lundin Johan; Joensuu Heikki; Furneaux Henry; Hla Timothy; Haglund Caj; Ristimäki Ari
Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Cancer research 2005;65(6):2157-61.
2005: Sivula Anna; Talvensaari-Mattila Anne; Lundin Johan; Joensuu Heikki; Haglund Caj; Ristimäki Ari; Turpeenniemi-Hujanen Taina
Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.
Breast cancer research and treatment 2005;89(3):215-20.
2005: Koljonen Virve; Lassus Patrik; Tukiainen Erkki; Ristimäki Ari; Haglund Caj; Böhling Tom
Cyclooxygenase-2 expression in primary Merkel cell carcinoma.
Journal of cutaneous pathology 2005;32(1):55-8.
2005: Heinonen Mira; Ristimäki Ari
[Coxibs in treatment and prevention of cancer]
Duodecim; lääketieteellinen aikakauskirja 2005;121(9):929-31.
2004: Udd Lina; Katajisto Pekka; Rossi Derrick J; Lepistö Anna; Lahesmaa Anna-Maria; Ylikorkala Antti; Järvinen Heikki J; Ristimäki Ari P; Mäkelä Tomi P
Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.
Gastroenterology 2004;127(4):1030-7.
2004: Siironen P; Ristimäki A; Nordling S; Louhimo J; Haapiainen R; Haglund C
Expression of COX-2 is increased with age in papillary thyroid cancer.
Histopathology 2004;44(5):490-7.
2004: Bizik J; Kankuri E; Ristimäki A; Taïeb A; Vapaatalo H; Lubitz W; Vaheri A
Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression.
Cell death and differentiation 2004;11(2):183-95.
2004: Erkinheimo Tiina-Liisa; Lassus Heini; Finne Patrik; van Rees Bastiaan P; Leminen Arto; Ylikorkala Olavi; Haglund Caj; Butzow Ralf; Ristimäki Ari
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):538-45.
2004: Udd Lina; Katajisto Pekka; Rossi Derrick; Lepistö Anna; Lahesmaa Anna-Maria; Ylikorkala Antti; Järvinen Heikki J; Ristimäki Ari; Mäkelä Tomi
[From animal models to human trials of Peutz-Jeghers syndrome]
Duodecim; lääketieteellinen aikakauskirja 2004;120(19):2353-4.
2004: Ristimäki Ari
Cyclooxygenase 2: from inflammation to carcinogenesis.
Novartis Foundation symposium 2004;256():215-21; discussion 221-6, 259-69.
2003: Buskens C J; Sivula A; van Rees B P; Haglund C; Offerhaus G J A; van Lanschot J J B; Ristimäki A
Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.
Gut 2003;52(12):1678-83.
2003: Erkinheimo Tiina-Liisa; Lassus Heini; Sivula Anna; Sengupta Sibani; Furneaux Henry; Hla Timothy; Haglund Caj; Butzow Ralf; Ristimäki Ari
Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.
Cancer research 2003;63(22):7591-4.
2003: Sudbø J; Reith A; Flørenes V A; Nesland J M; Ristimäki A; Bryne M
COX-2 expression in striated muscle under physiological conditions.
Oral diseases 2003;9(6):313-6.
2003: van Rees Bastiaan P; Sivula Anna; Thorén Staffan; Yokozaki Hiroshi; Jakobsson Per-Johan; Offerhaus G Johan A; Ristimäki Ari
Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.
International journal of cancer. Journal international du cancer 2003;107(4):551-6.
2003: Zhang Fan; Lundin Mikael; Ristimäki Ari; Heikkilä Päivi; Lundin Johan; Isola Jorma; Joensuu Heikki; Laiho Marikki
Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.
Cancer research 2003;63(16):5005-10.
2003: Sudbø Jon; Ristimäki Ari; Sondresen Jan Erik; Kildal Wanja; Boysen Morten; Koppang Hanna S; Reith Albrecht; Risberg Björn; Nesland Jahn M; Bryne Magne
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.
Oral oncology 2003;39(5):497-505.
2003: Saukkonen Kirsi; Tomasetto Catherine; Narko Kirsi; Rio Marie-Christine; Ristimäki Ari
Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Cancer research 2003;63(12):3032-6.
2003: Buskens C J; Ristimäki A; Offerhaus G J A; Richel D J; van Lanschot J J B
Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
Scandinavian journal of gastroenterology. Supplement 2003;(239):87-93.
2002: Salo Jarmo A; Ristimäki Ari; Salminen Jukka T; Sirén Jukka
Intussusception and spontaneous amputation of the esophagus.
The Journal of thoracic and cardiovascular surgery 2002;124(1):205-6.
2002: Buskens Christianne J; Van Rees Bastiaan P; Sivula Anna; Reitsma Johannes B; Haglund Caj; Bosma Piter J; Offerhaus G Johan A; Van Lanschot J Jan B; Ristimäki Ari
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
Gastroenterology 2002;122(7):1800-7.
2002: Ristimäki Ari; Sivula Anna; Lundin Johan; Lundin Mikael; Salminen Tiina; Haglund Caj; Joensuu Heikki; Isola Jorma
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Cancer research 2002;62(3):632-5.
2002: van Rees Bastiaan P; Saukkonen Kirsi; Ristimäki Ari; Polkowski Wojciech; Tytgat Guido N J; Drillenburg Paul; Offerhaus G Johan A
Cyclooxygenase-2 expression during carcinogenesis in the human stomach.
The Journal of pathology 2002;196(2):171-9.
2001: Keller J J; Offerhaus G J; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello F M
Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4000-7.
2001: van Rees B P; Ristimäki A
Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract.
Scandinavian journal of gastroenterology 2001;36(9):897-903.
2001: Saukkonen K; Nieminen O; van Rees B; Vilkki S; Härkönen M; Juhola M; Mecklin J P; Sipponen P; Ristimäki A
Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):1923-31.
2001: Narko K; Saukkonen K; Ketola I; Bützow R; Heikinheimo M; Ristimäki A
Regulated expression of prostaglandin E(2) receptors EP2 and EP4 in human ovarian granulosa-luteal cells.
The Journal of clinical endocrinology and metabolism 2001;86(4):1765-8.
2001: Ristimäki A; Nieminen O; Saukkonen K; Hotakainen K; Nordling S; Haglund C
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
The American journal of pathology 2001;158(3):849-53.
2000: Erkinheimo T L; Saukkonen K; Narko K; Jalkanen J; Ylikorkala O; Ristimäki A
Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium.
The Journal of clinical endocrinology and metabolism 2000;85(9):3468-75.
2000: Ekman N; Arighi E; Rajantie I; Saharinen P; Ristimäki A; Silvennoinen O; Alitalo K
The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
Oncogene 2000;19(36):4151-8.
1999: Narko K; Enholm B; Mäkinen T; Ristimäki A
Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.
International journal of experimental pathology 1999;80(3):109-12.
1999: Lassus P; Ristimäki A; Ylikorkala O; Viinikka L; Andersson S
Vascular endothelial growth factor in human preterm lung.
American journal of respiratory and critical care medicine 1999;159(5 Pt 1):1429-33.
1999: Saukkonen K; Narko K; Ristimäki A
[Cyclo-oxygenase 2 in cancer]
Duodecim; lääketieteellinen aikakauskirja 1999;115(8):855-6.
1998: Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
Expression of cyclooxygenase-2 in human lung carcinoma.
Cancer research 1998;58(22):4997-5001.
1998: Wartiovaara U; Salven P; Mikkola H; Lassila R; Kaukonen J; Joukov V; Orpana A; Ristimäki A; Heikinheimo M; Joensuu H; Alitalo K; Palotie A
Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation.
Thrombosis and haemostasis 1998;80(1):171-5.
1998: Ristimäki A; Narko K; Enholm B; Joukov V; Alitalo K
Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C.
The Journal of biological chemistry 1998;273(14):8413-8.
1997: Laitinen M; Ristimäki A; Honkasalo M; Narko K; Paavonen K; Ritvos O
Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells.
Endocrinology 1997;138(11):4748-56.
1997: Narko K; Ritvos O; Ristimäki A
Induction of cyclooxygenase-2 and prostaglandin F2alpha receptor expression by interleukin-1beta in cultured human granulosa-luteal cells.
Endocrinology 1997;138(9):3638-44.
1997: Narko K; Ristimäki A; MacPhee M; Smith E; Haudenschild C C; Hla T
Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression.
The Journal of biological chemistry 1997;272(34):21455-60.
1997: Enholm B; Paavonen K; Ristimäki A; Kumar V; Gunji Y; Klefstrom J; Kivinen L; Laiho M; Olofsson B; Joukov V; Eriksson U; Alitalo K
Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia.
Oncogene 1997;14(20):2475-83.
1997: Ristimäki A; Honkanen N; Jänkälä H; Sipponen P; Härkönen M
Expression of cyclooxygenase-2 in human gastric carcinoma.
Cancer research 1997;57(7):1276-80.
1997: Ristimäki A; Jaatinen R; Ritvos O
Regulation of prostaglandin F2 alpha receptor expression in cultured human granulosa-luteal cells.
Endocrinology 1997;138(1):191-5.
1996: Ristimäki A; Narko K; Hla T
Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation.
The Biochemical journal 1996;318 ( Pt 1)():325-31.
1994: Appleby S B; Ristimäki A; Neilson K; Narko K; Hla T
Structure of the human cyclo-oxygenase-2 gene.
The Biochemical journal 1994;302 ( Pt 3)():723-7.
1994: Ristimäki A; Garfinkel S; Wessendorf J; Maciag T; Hla T
Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.
The Journal of biological chemistry 1994;269(16):11769-75.
1994: Crofford L J; Wilder R L; Ristimäki A P; Sano H; Remmers E F; Epps H R; Hla T
Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.
The Journal of clinical investigation 1994;93(3):1095-101.
1993: Hla T; Ristimäki A; Appleby S; Barriocanal J G
Cyclooxygenase gene expression in inflammation and angiogenesis.
Annals of the New York Academy of Sciences 1993;696():197-204.
1991: Ristimäki A; Renkonen R; Saijonmaa O; Ylikorkala O; Viinikka L
Human serum stimulates endothelin-1 synthesis more potently than prostacyclin production by cultured vascular endothelial cells.
Life sciences 1991;49(8):603-9.
1990: Saijonmaa O; Ristimäki A; Fyhrquist F
Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells.
Biochemical and biophysical research communications 1990;173(2):514-20.
1989: Ristimäki A
Transforming growth factor alpha stimulates prostacyclin production by cultured human vascular endothelial cells more potently than epidermal growth factor.
Biochemical and biophysical research communications 1989;160(3):1100-5.
1988: Renkonen R; Ristimäki A; Häyry P
Interferon-gamma protects human endothelial cells from lymphokine-activated killer cell-mediated lysis.
European journal of immunology 1988;18(11):1839-42.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ari Ristimäki

Research Profile (preview)

Chemicals & Drugs

Procedures

Disorders

Physiology

Living Beings

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ari Ristimäki (preview)

All Publications